Editor’s Note: Find the latest COVID-19 news and guidance from Medscape Coronavirus Resource Center..
Scientists are working overtime to gain knowledge about the long-term effects of COVID-19 as authorities vie for the public release of vaccines and protective equipment, Anthony Forch, MD, said today’s White House. Said in an extensive briefing at.
“Many of you are aware of what has long been called a’long COVID’,” said Fauci, chief medical adviser to the White House COVID-19 response team. “But in reality, it is an acute sequela of SARS-CoV-2 infection and is now called” PASC “or PASC. “
He said the National Institutes of Health yesterday launched an initiative to further study what Fauci called “alert” and “mysterious.”
He emphasized that even patients with moderate infections can develop PASC. Symptoms include malaise. Gastrointestinal problems; “brain fog”, or inability to focus; depressionAnxiety; Sleep disorders; And in extreme cases, impaired vital capacity.
“New symptoms can occur after infection, or they progress over time and last for months,” Fauci continues. “They range from mild or annoying to actually totally helpless,” he mentioned. Survey From a researcher at the University of Washington Published online February 19 JAMA network opened. In that study, more than 30% of 177 participants reported symptoms that persisted for up to 9 months.
“It’s very difficult to treat something when you don’t know what the target of the treatment is,” Forch said. “There are many important questions to answer in the end of this series of initiatives.”
The White House Distributes J & J Vaccines “Do Not Waste Time”
Scientists at the US Food and Drug Administration have determined that the Johnson & Johnson vaccine is safe and effective. Review Released today. As soon as the single-dose vaccine gets an emergency use authorization (scheduled for later this week), the government will begin work to distribute it.
“The governor has carefully planned his efforts to prepare for the possibility of a new vaccine,” White House COVID-19 coordinator Jeff Seients said at a news conference this morning. “Once approved, we are ready to deploy this vaccine without delay.”
The Johnson & Johnson vaccine is the third pandemic that killed more than 500,000 Americans and was found to be more than 85% effective in preventing severe illness and 66% overall. ..
Zyentz said that if an emergency use authorization is granted, there will be 3-4 million doses by next week and 20 million doses planned by the end of March. Johnson & Johnson is contractually required to administer 100 million doses by the end of June.
“While we wait for a decision, we want Americans to know that we are working, so if an emergency use authorization is given, we will give Americans a life-saving vaccine. You don’t waste time getting it in your arms, “Zients said.
When the Biden administration came to power five weeks ago, Mr. Seiens said it was clear that the company was lagging behind in manufacturing. Since then, the White House has supported equipment and raw materials to accelerate the process.
“I was disappointed when we arrived, and I think the progress is real,” said Zyents.
The White House response team also sent 25 million cloth masks for adults and children to health centers and food banks across the country as an ongoing effort to protect underserved Americans during briefings. Announced that it will be delivered.
Follow Medscape for more news. Facebook, twitter, Instagram, And YouTube.
